BTK and B-cell chronic lymphocytic leukemia: Additionally, the impact of BTKis on other immune cells, such as T cells and macrophages, can potentially lead to unexpected alterations in immune responses, underlining the need for more comprehensive monitoring to advance our understanding of the mechanisms of BTK inhibition in CLL and the importance of a personalized approach to patient management.